Keywords: بدون نشانه; αS; alpha-synuclein; PD; Parkinson's disease; ER/M; endoplasmic reticulum/microsomes; HMW; high molecular weight; SpC; spinal cord; Ctx; cortex; PreS; presymptomatic; Tg; transgenic; nTg; non-Tg; α-Synuclein; Microsomes; Endoplasmic reticulum; Oligomers
مقالات ISI بدون نشانه (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بدون نشانه; Huntington's disease; Emotion regulation; Emotion recognition; Emotional awareness; Presymptomatic; Premanifest; Emotional processing;
Keywords: بدون نشانه; Alzheimer's disease; Dementia; Amyloid cascade hypothesis; Prevention; Intervention; Genetic; Presymptomatic; Diagnostic criteria;
Keywords: بدون نشانه; Preclinical; Presymptomatic; Neurodegenerative disorders; Movement disorders; Natural history
Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers
Keywords: بدون نشانه; GRN; progranulin; pGRN+; presymptomatic progranulin mutation carriers; GRN+; symptomatic progranulin mutation carriers; yCTL; young healthy controls; eCTL; elderly healthy controls; FTD; frontotemporal degeneration; GM; gray matter; WM; white matter; GMD;
« Quand l'annonce du diagnostic médical devient un enjeu d'accompagnement. Enquête au sein du protocole du test présymptomatique de la maladie de Huntington »
Keywords: بدون نشانه; Accompagnement; Maladie de Huntington; Ãthique; Génétique; Présymptomatique; Supportive care; Huntington's disease; Ethical code; Genetic; Presymptomatic;
White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort
Keywords: بدون نشانه; PS; Presymptomatic; S; Symptomatic; FTD; Frontotemporal dementia; WMH; White matter hyperintensity; IQR; Inter Quartile Range; CI; Confidence interval; TIV; Total Intracranial volume;
Evolving brain structural changes in PSEN1 mutation carriers
Keywords: بدون نشانه; Alzheimer's disease; Biomarkers; Cortical thickness; Presenilin 1; Presymptomatic;
Role of glutathione S-transferases in the spinocerebellar ataxia type 2 clinical phenotype
Keywords: بدون نشانه; Oxidative stress; Polyglutamine disease; Spinocerebellar ataxia type 2; Glutathione S-transferase; Antioxidant enzymes; Presymptomatic;
Presymptomatic late-onset Pompe disease identified by the dried blood spot test
Keywords: بدون نشانه; Pompe disease; Acid maltase deficiency; Late-onset; Juvenile-onset; Dried blood spot test; GAA; Presymptomatic; Splice-site mutation; cDNA analysis; Enzyme activity; c.â32â13T>G mutation;
Presymptomatic Parkinson's disease: The Arizona experience
Keywords: بدون نشانه; Parkinson's Disease; Presymptomatic; Lewy body; Brain Bank; EEG; EMG
White matter integrity and vulnerability to Alzheimer's disease: Preliminary findings and future directions
Keywords: بدون نشانه; DTI; Diffusion tensor imaging; APOE; Presymptomatic; Alzheimer's; Alzheimer's risk
Differential gene expression and apoptosis markers in presymptomatic scrapie affected sheep
Keywords: بدون نشانه; Apoptosis; Prion; Scrapie; Mitochondrial pathway; Presymptomatic
Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments
Keywords: بدون نشانه; Alzheimer's disease; Brain imaging; Biomarkers; Clinical trials; Positron emission tomography; Magnetic resonance imaging; Cerebrospinal fluid; Dementia; Mild cognitive impairment; Preclinical; Presymptomatic; Treatment; Prevention
Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype
Keywords: بدون نشانه; FTLD-tau Pick's disease subtype; Presymptomatic; Pick bodies; Three-repeat tau; Glial inclusion; Autopsy
Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis
Keywords: بدون نشانه; Amyotrophic lateral sclerosis; ALS; Cyclin-dependent kinase 5; cdk5; G93A hSOD1; Transgenic mice; Muscle; MyoD; Cyclin D1; Presymptomatic
Neuroprotection for Huntington's Disease: Ready, Set, Slow
Keywords: بدون نشانه; Huntington's disease; neuroprotection; disease modification; neurogenetics; genetic testing; clinical trials; presymptomatic; premanifest;